Philippines, Moderna Reach 13M Vaccine Doses Supply Pact

by Vandana Singh, Benzinga Editor

March 8, 2021 7:09 AM | 1 min read |

Moderna Inc (NASDAQ: MRNA) has agreed to supply the Philippines government with 13 million doses of its COVID-19 vaccine.
Deliveries are set to begin in mid-2021.
The company's COVID-19 vaccine is not currently approved for use in the country, and it will work with regulators to pursue necessary approvals before distribution.
The company also anticipates a separate deal with the Philippines government and private sector to supply an additional 7 million doses.
The Philippines regulator has so far approved for emergency use COVID-19 vaccines developed by Pfizer Inc (NYSE: PFE)/BioNTech SE (NASDAQ: BNTX), AstraZeneca Plc (NASDAQ: AZN), and Sinovac Biotech (NASDAQ: SVA).
Price Action: MRNA shares are down 2.4% at $129.01 in premarket trading on the last check Monday.

Posted In:

Biotech News Health Care General COVID-19 Vaccine

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.